课题基金 / 基金详情

siRNA-based Gold Nanoparticles as a Therapeutic Enhancer for Triple Negative Breast Cancer (TNBC) Radiotherapy

siRNA-based Gold Nanoparticles as a Therapeutic Enhancer for Triple Negative Breast Cancer (TNBC) Radiotherapy
基于 siRNA 的金纳米颗粒作为三阴性乳腺癌 (TNBC) 放射治疗的治疗增强剂
批准号:
10729127
负责人:
Branislava Janic
金额:
$7.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-10 至 2025-06-30
关键词:
AdjuvantAnimalsBreast Cancer CellBreast Cancer ModelBreast Cancer therapyCell SurvivalCellsChemicalsClinicalCombination Drug TherapyCombination immunotherapyDNA DamageDataDrug CarriersDrug Delivery SystemsDyesEnhancersEnvironmentEnzyme-Linked Immunosorbent AssayExhibitsFutureGoalsGrowthImmuneImmune systemImmunologic StimulationImmunosuppressionImmunotherapeutic agentImmunotherapyIn VitroIncubatedInterventionMalignant NeoplasmsMeasuresMicroscopyMolecularMouse Cell LineMusNatureNeoadjuvant TherapyNeoplasm MetastasisOpticsOutcomePathway interactionsPatientsPatternPhenotypePrimary NeoplasmProductionPrognosisPropertyPublic HealthPublishingQuantitative Reverse Transcriptase PCRRNA chemical synthesisRNA deliveryRadiationRadiation therapyRadiation-Sensitizing AgentsRadiosensitizationResearchRoleSmall Interfering RNASurvival RateTestingTherapeuticTherapeutic EffectTherapeutic immunosuppressionTransforming Growth Factor betaTransmission Electron MicroscopyTreatment EfficacyTumor ImmunityTumor TissueTumor-infiltrating immune cellsWorkXenograft Modelanti-canceranti-tumor immune responseantitumor effectcancer cellcancer immunotherapycancer radiation therapycancer typecyanine dye 5cytokinedesignimmune checkpoint blockersimmunogenic cell deathimmunogenicityimmunomodulatory therapiesimmunoregulationimprovedin vivoin vivo optical imaginginnovationinterestmalignant breast neoplasmmouse modelmultimodalitynanoGoldnovel strategiesprospectiveradiation effectrecruitresponsetreatment responsetriple-negative invasive breast carcinomatumortumor growthtumor microenvironmentuptakezeta potential

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
摘要
英文摘要
ABSTRACT Radiation therapy (RT) modulates immunological properties of tumor microenvironment (TME) to stimulate antitumor immune response. However, RT initiates immunosuppressive mechanisms as well and therefore diminishing the effects of RT immuno-stimulation. One of the main RT immunosuppressive modes is exerted by an increase in TGF production that in breast cancers (BC) has an additive effect on already high TGF levels produced by cancer cells themselves. Triple negative breast cancer (TNBC) in particular, was demonstrated to have higher TGF levels compared to other BCs, and this finding correlated with increased tumor grade and invasiveness, and a diminished patient survival. Consequently, RT induced increase in TGF within the TME may further potentiate invasiveness and metastatic potential of TNBC. Due to stimulatory aspects of RT immunomodulation, RT has gained interest as a prospective therapeutic enhancer in cancer immunotherapy, such as immune checkpoint blockers, that has shown great potential in improving local control and overall survival in select cancers. Unfortunately, in most forms of BC, including TNBC, response to immunotherapy remains modest. Our long-term goal is to use RT to enhance TNBC response to immunotherapy by taking advantage of RT immunomodulatory potential. Antitumor RT effects, including TME immunomodulation can be improved by using radiosensitizers, such as gold nanoparticles (AuNP). Furthermore, AuNPs can also serve as a drug delivery system by conjugation of small interfering RNAs (siRNAs). In this project we propose to use AuNPs functionally modified by TGF siRNA to simultaneously enhance RT immunomodulation and counteract the immunosuppressive effects related to the increased TGF production. This approach will enhance RT antitumor effects and create a favorable TME environment for better response to future immunotherapies. This will be tested by the following specific aims: Aim 1: To synthesize and characterize AuNP-siRNATGF1; Aim 2: To investigate the therapeutic effect of combination of RT and AuNP-siRNATGFβ1 in in vitro and in vivo mouse TNBC model. The proposed studies in determining the potential of AuNPs simultaneously target antitumor and immunomodulatory RT effects will provide critical information for improving TNBC response to immune checkpoint blockers and for designing future RT/ immune checkpoint blockers multimodal TNBC therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金